Notably, CD4+ and CD8+ cell subsets could be depleted before immunization or tumour challenge in BALB/c mice, without any significant effect on inhibition of tumour growth, while the combined depletion in the induction phase abrogated tumour protection. The gene discussed is CD4; the disease is neoplasm.